QA: LIXTE BIOTECHNOLOGY HOLDINGS INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001335105_2019_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001335105')"}

Graph

Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.

  xvar xval
0 AssetsCurrent 4,334,445
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 2,293
4 LiabilitiesCurrent 210,915
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,097,348
9 ResearchAndDevelopmentExpense 40,703
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 4,923
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,336,738
1 Liabilities 210,915
2 Expenses 2,138,051
3 Revenues 0
4 StockholdersEquity 4,125,823
5 NetIncome -2,133,128
6 ComprehensiveNetIncome -2,133,128
7 BaseVar 3,345,314
8 EconomicCapitalRatio 2.18

Edgar->Model Mapping

Feature Distribution

Change over Time